Cell Source, Inc. (CLCS)
OTCMKTS: CLCS · Delayed Price · USD
0.0008
+0.0006 (300.00%)
Jul 25, 2024, 4:00 PM EDT - Market closed
Company Description
Cell Source, Inc., a biotechnology company, engages in developing cell therapy treatments based on the management of immune tolerance.
Its lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses.
The company’s Veto Cell technology is used in various applications, including treatment of lymphoma, leukemia, and multiple myeloma through facilitation of the stem cell transplantation acceptance, as well as treatment of end stage kidney disease; other non-malignant organ diseases through organ transplantation; and various cancers and non-malignant diseases.
Cell Source, Inc. is headquartered in New York, New York.
Cell Source, Inc.
| Country | NY |
| Founded | 2011 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1 |
| CEO | Itamar Shimrat |
Contact Details
Address: 57 West 57th Street, Suite 400 New York, New York 10019 United States | |
| Phone | 646-612-7554 |
| Website | cell-source.com |
Stock Details
| Ticker Symbol | CLCS |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001569340 |
| CUSIP Number | 15114L104 |
| ISIN Number | US15114L1044 |
| Employer ID | 32-0379665 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Itamar Shimrat | Chief Executive Officer, President and Chief Financial Officer |
| Dr. Dennis M. Brown B.Sc., M.A., Ph.D. | Executive Chairman |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 24, 2024 | 10-K | Annual Report |
| Apr 9, 2024 | 8-K | Current Report |
| Apr 1, 2024 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| Nov 9, 2023 | 10-Q | Quarterly Report |
| Oct 6, 2023 | D | Notice of Exempt Offering of Securities |
| Sep 19, 2023 | 10-Q | Quarterly Report |
| Aug 23, 2023 | 10-Q | Quarterly Report |
| Aug 15, 2023 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| Aug 8, 2023 | 10-K | Annual Report |
| May 16, 2023 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |